Banner Alzheimer's Institute
Phoenix, Arizona, 85006, United States
Location status: Recruiting
Location contact
Jessica Langbaum, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT02022943
The Alzheimer's Prevention Registry (www.endALZnow.org) will collect contact and demographic information on individuals. The objective is to provide information the latest news and advances in Alzheimer's prevention research, and to inform enrollees about research studies in their community. Enrolled individuals will receive regular email communications. As research studies become available, individuals will be notified via email with information as to how proceed should they be interested. Registry enrollees are under no obligation to participate in a research study. Study opportunities may include surveys, healthy lifestyle interventions (e.g., diet, exercise), memory & thinking tests, brain scans, and investigational drug trials. To join the Registry, please visit www.endALZnow.org
Interested in participating?
Request Info18 year–110 year
All sexes
Observational
Phoenix, Arizona, 85006, United States
Location status: Recruiting
Jessica Langbaum, PhD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 16 years
Time frame: 16 years
Time frame: 16 years
Contact information is provided by the study sponsor or research team.
Banner Health
Other
Alzheimer's Prevention Registry
Acronym: APR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04396873
ALS, Alzheimer Disease
Bethesda, Maryland, United States
View Trial DetailsNCT06088121
Alzheimer Disease, Alzheimer's Disease
Incheon, Bupyeong 6(yuk)-dong, Bupyeong-gu, South Korea
View Trial DetailsNCT06411561
Alzheimer Disease, Alzheimer's Disease
Seattle, Washington, United States
View Trial DetailsNCT06384573
Alzheimer Disease, Alzheimer's Disease
Birmingham, Alabama, United States
View Trial Details